2019 American Transplant Congress
Treatment of Latent Tuberculosis Infection with Short-Course Regimens in Potential Living Kidney Donors
Medicine, University of Miami, Miami, FL
*Purpose: Treatment data for latent tuberculosis infection (LTBI) among potential living kidney donors is scarce. The use of 12-week isoniazid (INH) and rifapentine (RPT) in…2019 American Transplant Congress
Preoperative Marginal Factors Do Not Affect the Medically Complex Living Donors for Kidney Transplantation
Nagoya Daini Red Cross Hospital, Nagoya Aichi, Japan
*Purpose: Recently, medically complex living donors with marginal factors including hypertension, dyslipidemia, glucose intolerance, and obesity are increasing. The impact of preoperative marginal factors on…2019 American Transplant Congress
Evolution Of Right Laparoscopic Nephrectomy, Report Of A Tertiary Care Center In Mexico
Transplant Department, Instituto Mexicano Del Seguro Social, Mexico City, Mexico
*Purpose: Aim: The minimally-invasive approach to donor nephrectomy has been primarily driven for nephrectomy in the living donor; nevertheless, Right Nephrectomy (RN) constitutes a major…2019 American Transplant Congress
Variation in Living Donor Kidney Transplantation and the Impact of Medicaid Expansion
*Purpose: Living donor kidney transplant (LDKTx) is the preferred treatment for end-stage renal disease (ESRD). Medicaid Expansion increased insurance coverage and this influx of insured…2019 American Transplant Congress
HbA1c as a Noninvasive Predictor of Chronic Histopathologic Changes in Living Donors for Kidney Transplantation
*Purpose: The degree of chronic histopathologic changes in renal allografts, including interstitial fibrosis, tubular atrophy, and arteriolar hyalinosis, can have clinical implications in long-term allograft…2019 American Transplant Congress
Patients With Biliary Complications Following Orthotopic Liver Transplantation Can Be Successfully Managed By Serial Endoscopic Retrograde Cholangio-pancreatography
Henry Ford Hospital, Detroit, MI
*Purpose: We evaluated the quality of endoscopic intervention for biliary complications after liver transplantation in a diverse urban center.*Methods: A retrospective chart review of liver…2019 American Transplant Congress
Osmotic Demyelination Syndrome after Liver Transplantation- Etiology and Treatment Options
*Purpose: Orthotopic liver transplantation (OLT) is the only effective therapy for patients with end stage liver failure that increases long-term survival, but is not without…2019 American Transplant Congress
Risk Factors for Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation. An Analysis of UNOS Registry
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The Model for End-Stage Liver Disease (MELD) score has been used for predicting waitlist outcomes in patients with cirrhosis. However, the post-transplant prognostic value…2019 American Transplant Congress
Meld Score / Grwr Ratio (meldgr) Can Predict Surgical Outcomes And Prognosis Of The Recipients In Adult-to-adult Living Donor Liver Transplantation
Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Tsu, Japan
*Purpose: In living donor liver transplantation (LDLT), various risk factors have been identified among both recipient and donor factors, such as Model for End-Stage Liver…2019 American Transplant Congress
Effects of Thalidomide and Dexamethasone Co-Treatment on CD8+ T Cells
*Purpose: Thalidomide (TM) is known to have anti-cancer and anti-inflammatory effects and dexamethasone (DX) has been reported that it also reduces inflammation and inhibits inflammatory…
- 1
- 2
- 3
- …
- 214
- Next Page »